Last 12 months
Inside the activity.
2 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2024 Filed Jun 24, 2024 20:07 UTC |
Puhlmann MarkusChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $10.65 | $0.00 |
DisclosureSEC source: 0000950170-24-076710 · ownership.xml · derivative · entry 1 Puhlmann Markus · CIK 0001965071 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-06-20 F1 · derivative.exercise_date: Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:05 UTC |
Hunt Jonathan RobertChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $10.65 | $0.00 |
DisclosureSEC source: 0000950170-24-076695 · ownership.xml · derivative · entry 1 Hunt Jonathan Robert · CIK 0001375410 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-06-20 F1 · derivative.exercise_date: Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 11:48 UTC |
Hunt Jonathan RobertChief Financial Officer
|
PurchaseCommon Stock | 1,800 | $9.82 | $17,667.00 |
DisclosureSEC source: 0000950170-24-074594 · ownership.xml · nonDerivative · entry 1 Hunt Jonathan Robert · CIK 0001375410 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,971 Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 11:45 UTC |
Woods Lori ADirector
|
PurchaseCommon Stock | 83 | $10.80 | $896.40 |
DisclosureSEC source: 0000950170-24-074592 · ownership.xml · nonDerivative · entry 2 Woods Lori A · CIK 0001393007 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Woods Family Living Trust Disclosed balance after: 159,985 Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 11:45 UTC |
Woods Lori ADirector
|
PurchaseCommon Stock | 4,504 | $10.90 | $49,093.60 |
DisclosureSEC source: 0000950170-24-074592 · ownership.xml · nonDerivative · entry 1 Woods Lori A · CIK 0001393007 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Woods Family Living Trust Disclosed balance after: 159,902 Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 21:19 UTC |
Spoor Johan M.Director · CEO
|
PurchaseCommon Stock | 100,000 | $1.17 | $117,430.00 |
DisclosureSEC source: 0000950170-24-073145 · ownership.xml · nonDerivative · entry 1 Spoor Johan M. · CIK 0001535289 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,572 F1 · price: The price in column 4 is a weighted average price. The prices actually paid ranged from $1.1650 to $1.1800. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:02 UTC |
Woods Lori ADirector
|
PurchaseCommon Stock | 34,246 | $1.46 | $49,992.31 |
DisclosureSEC source: 0000950170-24-068638 · ownership.xml · nonDerivative · entry 1 Woods Lori A · CIK 0001393007 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Woods Family Living Trust Disclosed balance after: 1,553,984 Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 20:01 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 55,000 | $1.38 | $75,900.00 |
DisclosureSEC source: 0000950170-24-067945 · ownership.xml · nonDerivative · entry 1 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,792 Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 20:05 UTC |
Hunt Jonathan RobertChief Financial Officer
|
PurchaseCommon Stock | 12,000 | $1.40 | $16,800.00 |
DisclosureSEC source: 0000950170-24-067953 · ownership.xml · nonDerivative · entry 2 Hunt Jonathan Robert · CIK 0001375410 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,716 Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 20:05 UTC |
Hunt Jonathan RobertChief Financial Officer
|
PurchaseCommon Stock | 13,006 | $1.40 | $18,207.10 |
DisclosureSEC source: 0000950170-24-067953 · ownership.xml · nonDerivative · entry 1 Hunt Jonathan Robert · CIK 0001375410 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,716 Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:05 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 18,656 | $1.34 | $24,999.04 |
DisclosureSEC source: 0000950170-24-066557 · ownership.xml · nonDerivative · entry 2 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,792 Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:05 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 11,375 | $1.32 | $15,015.00 |
DisclosureSEC source: 0000950170-24-066557 · ownership.xml · nonDerivative · entry 1 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,136 Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 20:35 UTC |
Austin Mark JohnVP Finance/Prin Fin&Acct Offic
|
Exercise / conversionStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-047645 · ownership.xml · derivative · entry 2 Austin Mark John · CIK 0001713059 · VP Finance/Prin Fin&Acct Offic 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 150,000 shares Expires 2032-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Option is fully vested. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 20:35 UTC |
Austin Mark JohnVP Finance/Prin Fin&Acct Offic
|
Exercise / conversionCommon stock | 30,000 | $0.36 | $10,800.00 |
DisclosureSEC source: 0000950170-24-047645 · ownership.xml · nonDerivative · entry 1 Austin Mark John · CIK 0001713059 · VP Finance/Prin Fin&Acct Offic 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 16:24 UTC |
Lantheus Alpha Therapy, LLC10% owner
Lantheus Holdings, Inc.10% owner
|
PurchaseCommon Stock | 60,431,039 | $0.95 | $57,409,487.05 |
DisclosureSEC source: 0000950170-24-028446 · ownership.xml · nonDerivative · entry 1 Lantheus Alpha Therapy, LLC · CIK 0002010224 · 10% owner Lantheus Holdings, Inc. · CIK 0001521036 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,773,394 F1 · kind: Represents securities directly held by Lantheus Alpha Therapy, LLC, ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership. F1 · ownership.direct: Represents securities directly held by Lantheus Alpha Therapy, LLC, ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:53 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 3,500 | $0.70 | $2,450.00 |
DisclosureSEC source: 0001437749-24-002837 · rdgdoc.xml · nonDerivative · entry 6 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,761 Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:53 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 42,879 | $0.72 | $30,872.88 |
DisclosureSEC source: 0001437749-24-002837 · rdgdoc.xml · nonDerivative · entry 5 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,261 Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:53 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 57,121 | $0.71 | $40,555.91 |
DisclosureSEC source: 0001437749-24-002837 · rdgdoc.xml · nonDerivative · entry 4 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,382 Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:53 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 5,127 | $0.71 | $3,640.17 |
DisclosureSEC source: 0001437749-24-002837 · rdgdoc.xml · nonDerivative · entry 3 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,261 Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:53 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 18,579 | $0.71 | $13,191.09 |
DisclosureSEC source: 0001437749-24-002837 · rdgdoc.xml · nonDerivative · entry 2 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,134 Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 21,235 | $0.64 | $13,590.40 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 8 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,555 Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 4,031 | $0.64 | $2,579.84 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 7 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,320 Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 50,000 | $0.54 | $27,000.00 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 6 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,289 Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 25,000 | $0.55 | $13,750.00 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 5 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,289 Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 8,513 | $0.59 | $5,022.67 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 4 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,289 Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 14,850 | $0.61 | $9,058.50 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 3 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,776 Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:57 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 12,250 | $0.61 | $7,472.50 |
DisclosureSEC source: 0001437749-24-002571 · rdgdoc.xml · nonDerivative · entry 2 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,926 Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 22:38 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 22,134 | $0.49 | $10,845.66 |
DisclosureSEC source: 0001437749-24-002322 · rdgdoc.xml · nonDerivative · entry 2 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,676 Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 22:40 UTC |
Puhlmann MarkusChief Medical Officer
|
PurchaseCommon Stock | 280,000 | $0.50 | $139,888.00 |
DisclosureSEC source: 0001437749-24-002324 · rdgdoc.xml · nonDerivative · entry 1 Puhlmann Markus · CIK 0001965071 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,375,425 F1 · price: This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4871 to $0.5000, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 22:38 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 29,862 | $0.49 | $14,632.38 |
DisclosureSEC source: 0001437749-24-002322 · rdgdoc.xml · nonDerivative · entry 1 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,542 Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 22:00 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 3,663 | $0.33 | $1,202.56 |
DisclosureSEC source: 0001437749-23-035321 · rdgdoc.xml · nonDerivative · entry 1 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By RFW3 Revocable Trust Disclosed balance after: 3,663 F1 · price: This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3249 to $0.3300, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 00:10 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 13,680 | $0.32 | $4,377.60 |
DisclosureSEC source: 0001437749-23-034933 · rdgdoc.xml · nonDerivative · entry 2 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,680 Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 00:09 UTC |
Puhlmann MarkusChief Medical Officer
|
PurchaseCommon Stock | 400,000 | $0.34 | $137,000.00 |
DisclosureSEC source: 0001437749-23-034931 · rdgdoc.xml · nonDerivative · entry 3 Puhlmann Markus · CIK 0001965071 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,095,425 Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 00:11 UTC |
Hunt Jonathan RobertChief Financial Officer
|
PurchaseCommon Stock | 125,000 | $0.26 | $32,337.50 |
DisclosureSEC source: 0001437749-23-034935 · rdgdoc.xml · nonDerivative · entry 1 Hunt Jonathan Robert · CIK 0001375410 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,710 Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 00:10 UTC |
Williamson Robert F IIIDirector
|
PurchaseCommon Stock | 10,000 | $0.26 | $2,600.00 |
DisclosureSEC source: 0001437749-23-034933 · rdgdoc.xml · nonDerivative · entry 1 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 00:09 UTC |
Puhlmann MarkusChief Medical Officer
|
PurchaseCommon Stock | 60,419 | $0.26 | $15,461.22 |
DisclosureSEC source: 0001437749-23-034931 · rdgdoc.xml · nonDerivative · entry 2 Puhlmann Markus · CIK 0001965071 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 695,425 Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:16 UTC |
Woods Lori ADirector
|
PurchaseCommon Stock | 152,962 | $0.27 | $41,284.44 |
DisclosureSEC source: 0001437749-23-034752 · rdgdoc.xml · nonDerivative · entry 2 Woods Lori A · CIK 0001393007 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Woods Family Living Trust Disclosed balance after: 1,519,738 Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:09 UTC |
Puhlmann MarkusChief Medical Officer
|
PurchaseCommon Stock | 135,006 | $0.27 | $36,276.11 |
DisclosureSEC source: 0001437749-23-034931 · rdgdoc.xml · nonDerivative · entry 1 Puhlmann Markus · CIK 0001965071 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 635,006 Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:16 UTC |
Woods Lori ADirector
|
PurchaseCommon Stock | 32,238 | $0.27 | $8,704.26 |
DisclosureSEC source: 0001437749-23-034752 · rdgdoc.xml · nonDerivative · entry 1 Woods Lori A · CIK 0001393007 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Woods Family Living Trust Disclosed balance after: 1,366,776 Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:44 UTC |
Puhlmann MarkusChief Medical Officer
|
GrantStock Options (right to buy) · Derivative | 1,477,619 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034481 · rdgdoc.xml · derivative · entry 1 Puhlmann Markus · CIK 0001965071 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,885,688 Underlying: Common Stock · 1,477,619 shares Expires 2033-12-12 F1 · derivative.exercise_date: 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:42 UTC |
Spoor Johan M.Director · CEO
|
GrantStock Options (right to buy) · Derivative | 3,338,878 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034479 · rdgdoc.xml · derivative · entry 1 Spoor Johan M. · CIK 0001535289 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,793,635 Underlying: Common Stock · 3,338,878 shares Expires 2033-12-12 F1 · derivative.exercise_date: 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:36 UTC |
Hunt Jonathan RobertChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 1,248,776 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034477 · rdgdoc.xml · derivative · entry 1 Hunt Jonathan Robert · CIK 0001375410 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,527,429 Underlying: Common Stock · 1,248,776 shares Expires 2033-12-12 F1 · derivative.exercise_date: 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:34 UTC |
Morich FrankDirector
|
GrantStock Options (right to buy) · Derivative | 230,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034475 · rdgdoc.xml · derivative · entry 1 Morich Frank · CIK 0001748615 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,037,471 Underlying: Common Stock · 230,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: 100% vests 12/12/2024. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:32 UTC |
Williamson Robert F IIIDirector
|
GrantStock Options (right to buy) · Derivative | 230,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034473 · rdgdoc.xml · derivative · entry 1 Williamson Robert F III · CIK 0001397331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,000 Underlying: Common Stock · 230,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: 100% vests 12/12/2024. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:30 UTC |
HENSON HEIDIDirector
|
GrantStock Options (right to buy) · Derivative | 230,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034470 · rdgdoc.xml · derivative · entry 1 HENSON HEIDI · CIK 0001283301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,000 Underlying: Common Stock · 230,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: 100% vests 12/12/2024. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:28 UTC |
Woods Lori ADirector
|
GrantStock Options (right to buy) · Derivative | 230,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001437749-23-034468 · rdgdoc.xml · derivative · entry 1 Woods Lori A · CIK 0001393007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,412,500 Underlying: Common Stock · 230,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: 100% vests 12/12/2024. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 20:47 UTC |
Streeter JenniferCOO & VP of HR
|
GrantStock Options (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001437749-23-017424 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,722,500 Underlying: Common Stock · 500,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: 25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 20:45 UTC |
Austin Mark JohnVP Finance/Prin Fin&Acct Offic
|
GrantStock Options (right to buy) · Derivative | 225,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001437749-23-017422 · rdgdoc.xml · derivative · entry 1 Austin Mark John · CIK 0001713059 · VP Finance/Prin Fin&Acct Offic 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773,115 Underlying: Common Stock · 225,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: 25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:34 UTC |
HENSON HEIDIDirector
|
GrantStock Options (right to buy) · Derivative | 230,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001437749-23-016757 · rdgdoc.xml · derivative · entry 2 HENSON HEIDI · CIK 0001283301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 230,000 shares Expires 2033-06-02 F2 · derivative.exercise_date: 100% vests 6/2/2024. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:34 UTC |
HENSON HEIDIDirector
|
GrantStock Options (right to buy) · Derivative | 470,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001437749-23-016757 · rdgdoc.xml · derivative · entry 1 HENSON HEIDI · CIK 0001283301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,000 Underlying: Common Stock · 470,000 shares Expires 2033-06-02 F1 · derivative.exercise_date: Vest monthly over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.